Position in IMVT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$359,914,548
+$73,584,589 QoQ
Shares Held
9,341,151
-19.0% QoQ
Ownership
4.52%
of shares outstanding
% of Portfolio
5.48%
of 13F equity value
Holder Rank
#2
of 224 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. IMVT ranks #1 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
This page
|
9,341,151 | $359,914,548 | |
| 2 | GPCR |
Structure Therapeutics Inc.
|
4,740,072 | $254,399,664 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,959,000 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
825,000 | $248,349,750 | |
| 5 | MANE |
Veradermics, Inc
|
2,000,000 | $245,880,000 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,666,768 | $230,786,377 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $193,319,289 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
3,307,481 | $189,254,062 |
All Filings in IMVT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $359,914,548 | 9,341,151 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $359,914,548 | 9,341,151 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $286,329,959 | 11,526,971 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $293,015,602 | 11,526,971 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $156,828,981 | 9,728,845 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $152,000,000 | 9,500,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $162,355,000 | 9,500,000 | Shares | Sole | 2025-05-15 | |
| 2025-03-19 | $179,360,000 | 9,500,000 | Shares | Sole | 2025-03-26 | |
| 2024-12-31 | $148,620,000 | 6,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $123,946,198 | 4,347,464 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $76,130,630 | 2,883,736 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,940,203 | 493,352 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $42,130,000 | 1,000,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $107,413,492 | 2,797,955 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $102,842,630 | 5,421,330 | Shares | Sole | 2023-09-06 | |
| 2023-03-31 | $115,281,440 | 7,432,717 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $172,352,500 | 9,710,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $55,020,172 | 9,860,246 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $36,874,500 | 9,455,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $39,807,617 | 7,224,613 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $40,683,000 | 4,775,000 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||